IDXG
Interpace Biosciences, Inc.
$6.51-0.47 (-6.73%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖AI Insight
Latest Insider Transactions
7 transactions (past 365 days)
| 2026-08-20 | 2026-08-20 | Burnell Thomas W. | CEO | Tax Payment | 581,718 | $1.61 | $936,566 |
| 2026-08-20 | 2026-08-20 | Burnell Thomas W. | CEO | Award | 554,018 | $2.02 | $1,119,116 |
| 2026-08-20 | 2026-08-20 | Burnell Thomas W. | CEO | Exercise Conversion | 1,966,763 | $0.00 | $0 |
| 2026-08-20 | 2026-08-20 | Mccarthy Christopher | CFO | Award | 277,009 | $2.02 | $559,558 |
| 2026-08-20 | 2026-08-20 | Mccarthy Christopher | CFO | Exercise Conversion | 277,009 | $0.00 | $0 |
| 2026-02-17 | 2026-01-20 | 1315 Capital Ii, L.P. | 10% Owner | Conversion | 9,405,941 | $2.02 | $19,000,001 |
| 2026-02-17 | 2026-01-20 | 1315 Capital Ii, L.P. | 10% Owner | Conversion | 19,000 | $0.00 | $0 |
IDXG
CEO
Exercise Conversion
$0
Burnell Thomas W.1,966,763 shares @ $0.00
Filed 2026-08-20Trade 2026-08-20
IDXG
CFO
Exercise Conversion
$0
Mccarthy Christopher277,009 shares @ $0.00
Filed 2026-08-20Trade 2026-08-20
IDXG
10% Owner
Conversion
$19M
1315 Capital Ii, L.P.9,405,941 shares @ $2.02
Filed 2026-02-17Trade 2026-01-20